News
RHHVF
410.00
-1.07%
-4.44
Health Rounds: Old cancer drug may help restore fertility for certain women
Reuters · 20h ago
AI Daily: Amazon’s AWS commits $1B toward new unit
TipRanks · 21h ago
Anthropic takes aim at pharma industry with Claude Science, STAT reports
TipRanks · 22h ago
Vertex Pharmaceuticals Has One Of The Widest And Most Durable Moats In Biotech
Seeking Alpha · 1d ago
Genentech announces priority review for Enspryng
TipRanks · 1d ago
Analysts Offer Insights on Healthcare Companies: Replimune Group (REPL) and Roche Holding AG (OtherRHHVF)
TipRanks · 1d ago
Roche's Genentech Receives FDA Priority Review For Enspryng As First At-Home Subcutaneous Treatment For Thyroid Eye Disease
Benzinga · 1d ago
FDA GRANTS PRIORITY REVIEW TO GENENTECH’S APPLICATION FOR ENSPRYNG, THE FIRST AND ONLY AT-HOME SUBCUTANEOUS TREATMENT OPTION FOR THYROID EYE DISEASE (TED)
Reuters · 1d ago
FDA grants priority review to Roche’s Enspryng for thyroid eye disease treatment option
PUBT · 1d ago
TG Therapeutics Surged 88%: Time To Be More Careful (Rating Downgrade)
Seeking Alpha · 2d ago
Roche announces launch of AXELIOS 1, a next-gen sequencing platform
TipRanks · 2d ago
Weekly Report: what happened at RHHVF last week (0622-0626)?
Weekly Report · 2d ago
Roche launches Axelios gene sequencer in a bid to loosen Illumina's grip
Reuters · 2d ago
Roche Launches AXELIOS 1, A Next-Generation Sequencing Platform Combining Accuracy, Speed, Scalability And Cost Efficiency For Research Laboratories
Benzinga · 2d ago
Novo Nordisk: 3 Key Reasons The 'Buy The Dip' Thesis Is Flawed
Seeking Alpha · 4d ago
Jazz Pharmaceuticals: Why It's Time To Cash Out (Rating Downgrade)
Seeking Alpha · 5d ago
Jade Biosciences names Vir Biotech ex-CMO Mark Eisner to board
PUBT · 5d ago
Is GSK Quietly Becoming An Oncology Powerhouse
Seeking Alpha · 6d ago
NeoGenomics appoints Flatiron Health ex-CEO Carolyn Starrett to board
PUBT · 6d ago
MapLight Therapeutics names Martin Babler, Troy Cox to board of directors
PUBT · 06/24 11:01
More
Webull provides a variety of real-time RHHVF stock news. You can receive the latest news about Roche Hldg through multiple platforms. This information may help you make smarter investment decisions.
About RHHVF
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.